Recently, we were able to show that pharmacological activation of Nrf2 inhibits NF-κB activity as well as the secretion of the pro-inflammatory cytokines IL-1β and IL-6 in an in vitro model of rheumatoid arthritis [28]. Here, NFKB1 is linked to rheumatoid arthritis.